Many believe that transcatheter aortic valve implantation is one of the most exciting and lucrative new technologies to hit the market providing an option for patients to sick to undergo open heart ...

The proposed decision memo also paves the way for triaging by chart review and enhancing flexibility for heart team decisions ...

Edwards Lifesciences (NYSE: EW) today announced the results from the RHEIA Trial, a first-of-its-kind trial focused exclusively on outcomes for women receiving transcatheter aortic valve implantation ...

High mortality in elderly patients followed over a decade might complicate the lessons learned compared with SAVR.

MIAMI BEACH — There are a lot of appetizing data being served this week at the Transcatheter Cardiovascular Thereapeutics (TCT) meeting in Miami, but one of the main courses is clearly transcatheter ...

In the first study to compare transcatheter aortic valve replacement or implantation to surgical aortic valve replacement exclusively in women, Edwards Lifescience Corp.’s Sapien 3 and Sapien 3 Ultra ...

Medtronic scored a badly needed point in its heart valve struggles with rival Edwards Lifesciences when the European Patent Office (EPO; The Hague) ruled that Edwards' so-called Spenser patent was ...